BB-5523

N/A

Report date: 2024/07/03 17:10:53
NME

Base Information

Drug NameBB-5523
Drug Alias NameBB5523BB-5523
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMitogen-activated protein kinase kinase kinase kinase 1 inhibitorsVascular endothelial growth factor receptor 2 inhibitorsTRAF2 and NCK-interacting protein kinase inhibitors
TargetsMitogen-activated protein kinase kinase kinase kinase 1Vascular endothelial growth factor receptor 2TRAF2 and NCK-interacting protein kinase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesBroadenbio Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBroadenbio Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A